A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Stopped Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizure

Conditions

• Drug-Resistant Epilepsy
• Focal-Onset Seizures

Interventions

• DRUG: Padsevonil
• DRUG: Placebo

Sponsor

UCB Biopharma SRL